Sterling Capital Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$176K Buy
1,174
+365
+45% +$39.7K ﹤0.01% 1256
2026
Q1
$74.7K Buy
809
+12
+2% +$1.21K ﹤0.01% 1494
2025
Q4
$81.4K Buy
797
+506
+174% +$45.3K ﹤0.01% 1615
2025
Q3
$18.2K Sell
291
-2
-0.7% -$109 ﹤0.01% 2197
2025
Q2
$15.2K Buy
293
+166
+131% +$7.41K ﹤0.01% 1897
2025
Q1
$5.41K Buy
127
+8
+7% +$345 ﹤0.01% 2127
2024
Q4
$3.63K Sell
119
-1
-0.8% -$28 ﹤0.01% 2584
2024
Q3
$2.75K Buy
+120
New +$3.4K ﹤0.01% 2029

Other funds holding GH

Sterling Capital Management's GH Position: Q2 2026 in Review

Sterling Capital Management increased its Guardant Health (GH) stake by 45% in Q2 2026, buying an estimated $39.7K and bringing the position to 1,174 shares worth $176K. The position accounts for ﹤0.01% of the portfolio, ranked #1256.

Sterling Capital Management first reported a position in GH in Q3 2024 and has held it in 8 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Sterling Capital Management held 1,174 shares of Guardant Health worth $176K as of Q2 2026.
  • Sterling Capital Management bought 365 Guardant Health shares in Q2 2026, an estimated $39.7K.
  • Guardant Health made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #1256 holding.
  • Sterling Capital Management first reported a position in Guardant Health in Q3 2024 and has held it in 8 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.